5-amino-2,4-dihydroxy-alpha-methylphenylethylamine has been researched along with ibutamoren mesylate in 1 studies
Studies (5-amino-2,4-dihydroxy-alpha-methylphenylethylamine) | Trials (5-amino-2,4-dihydroxy-alpha-methylphenylethylamine) | Recent Studies (post-2010) (5-amino-2,4-dihydroxy-alpha-methylphenylethylamine) | Studies (ibutamoren mesylate) | Trials (ibutamoren mesylate) | Recent Studies (post-2010) (ibutamoren mesylate) |
---|---|---|---|---|---|
10 | 0 | 0 | 102 | 19 | 14 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, AR; Dickson, SL; Leng, G; Smith, RG; von Engelhardt, N; Von Englehardt, N | 1 |
1 other study(ies) available for 5-amino-2,4-dihydroxy-alpha-methylphenylethylamine and ibutamoren mesylate
Article | Year |
---|---|
Growth hormone secretagogue activation of the arcuate nucleus and brainstem occurs via a non-noradrenergic pathway.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Brain Stem; Growth Hormone; Growth Hormone-Releasing Hormone; Indoles; Male; Neurotoxins; Oligopeptides; Phenethylamines; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Spiro Compounds; Tyrosine 3-Monooxygenase | 2000 |